These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 892688

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Glucagon regulation of plasma ketone body concentration in human diabetes.
    Schade DS, Eaton RP.
    J Clin Invest; 1975 Nov; 56(5):1340-4. PubMed ID: 1184755
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE, Langlois M, Noacco C, Lorenzi M, Karam JH, Korsham PH.
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [Abstract] [Full Text] [Related]

  • 4. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH.
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.
    Kyner JL, Levy RI, Soeldner JS, Gleason RE, Fredrickson DS.
    J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689
    [Abstract] [Full Text] [Related]

  • 9. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC, Frisch F, Cyr D, Généreux P, Patterson BW, Giguère R, Baillargeon JP.
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metabolic and hormonal responses during a glucose controlled insulin infusion (Biostator) in subjects with impaired glucose tolerance.
    Ratzmann KP, Schneider U, Peters U, Ziegler M, Schulz B.
    Exp Clin Endocrinol; 1984 May; 83(3):334-42. PubMed ID: 6381073
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
    Li L, Yang GY.
    Zhonghua Yi Xue Za Zhi; 2004 Oct 02; 84(19):1645-8. PubMed ID: 15569462
    [Abstract] [Full Text] [Related]

  • 15. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ.
    Diabetes; 2008 Mar 02; 57(3):678-87. PubMed ID: 18057091
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of nicotinic acid on the plasma pancreatic glucagon, insulin and free fatty acid in diabetic subjects.
    Tasaka Y, Sekine M, Yoshida Y, Hirata Y.
    Horm Metab Res; 1976 Nov 02; 8(6):489. PubMed ID: 1002108
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.